baumannii Multidrug-Resistant Acinetobacter Ventilator-Associated Pneumonia by Inflammation in a Mouse Model of Azithromycin Attenuates Lung

Published Ahead of Print 3 June 2013. 10.1128/AAC.00457-13. 2013, 57(8):3883. DOI: Antimicrob. Agents Chemother. Kohno Kakeya, Hiroo Hasegawa, Hiroshige Mikamo and Shigeru Imamura, Taiga Miyazaki, Koichi Izumikawa, Hiroshi Yoshitomo Morinaga, Shigeki Nakamura, Yoshifumi Yosuke Harada, Yohei Migiyama, Kentaro Nagaoka, Koichi Yamada, Katsunori Yanagihara, Norihito Kaku, baumannii Multidrug-Resistant Acinetobacter Ventilator-Associated Pneumonia by Inflammation in a Mouse Model of Azithromycin Attenuates Lung

[1]  M. McConnell,et al.  Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. , 2013, FEMS microbiology reviews.

[2]  Eric P. Skaar,et al.  Host–microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection , 2012, Cellular microbiology.

[3]  J. Rello,et al.  Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia , 2010, European Respiratory Journal.

[4]  S. Brody,et al.  Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis , 2010, Respiratory research.

[5]  K. Kaye,et al.  Trends in Antimicrobial Resistance of Acinetobacter baumannii Isolates from a Metropolitan Detroit Health System , 2010, Antimicrobial Agents and Chemotherapy.

[6]  V. Tam,et al.  Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model. , 2010, The Journal of infectious diseases.

[7]  M. Kempf,et al.  The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia. , 2010, The Journal of infection.

[8]  C. Roussos,et al.  Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Lisa L Maragakis,et al.  Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Yehuda Carmeli,et al.  Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli , 2007, Antimicrobial Agents and Chemotherapy.

[11]  C. Price,et al.  Epidemiologic, Clinical, and Economic Evaluation of an Outbreak of Clonal Multidrug-Resistant Acinetobacter baumannii Infection in a Surgical Intensive Care Unit , 2007, Infection Control & Hospital Epidemiology.

[12]  J. Quinn,et al.  Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 , 2007, Journal of Clinical Microbiology.

[13]  M. Hentzer,et al.  Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr−/− Mice , 2007, Antimicrobial Agents and Chemotherapy.

[14]  J. Ramirez,et al.  A worldwide perspective of atypical pathogens in community-acquired pneumonia. , 2007, American journal of respiratory and critical care medicine.

[15]  M. Kaufmann,et al.  Identification of Acinetobacter baumannii by Detection of the blaOXA-51-like Carbapenemase Gene Intrinsic to This Species , 2006, Journal of Clinical Microbiology.

[16]  D. Wareham,et al.  In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases , 2006, Annals of Clinical Microbiology and Antimicrobials.

[17]  F. Can,et al.  In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. , 2006, International journal of antimicrobial agents.

[18]  P. Fournier,et al.  The epidemiology and control of Acinetobacter baumannii in health care facilities. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  K. Asano,et al.  Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice. , 2003, Mediators of inflammation.

[20]  F. Fernández-Cuenca,et al.  In vitro Activity of Azithromycin in Combination with Amikacin, Ceftazidime, Ciprofloxacin or Imipenem against Clinical Isolates of Acinetobacter baumannii , 2003, Chemotherapy.

[21]  C. Cabellos,et al.  Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii , 2002, Antimicrobial Agents and Chemotherapy.

[22]  Y. Hirakata,et al.  Effects of Parenterally Administered Ciprofloxacin in a Murine Model of Pulmonary Pseudomonas aeruginosa Infection Mimicking Ventilator-Associated Pneumonia , 2001, Chemotherapy.

[23]  M. Sole,et al.  Analysis of factors related to the development of ventilator-associated pneumonia: use of existing databases. , 2000, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[24]  F. J. Caballero,et al.  Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. , 2000, The Journal of antimicrobial chemotherapy.

[25]  M. Wolff,et al.  Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem , 1997, Antimicrobial agents and chemotherapy.

[26]  J. Golden,et al.  Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects , 1996, Antimicrobial agents and chemotherapy.

[27]  S. Kamihira,et al.  Clinical characteristics of tertiary hospital patients from whom Acinetobacter calcoaceticus-Acinetobacter baumannii complex strains were isolated. , 2012, Internal medicine.

[28]  R. Weinstein,et al.  Acinetobacter infection. , 2008, The New England journal of medicine.

[29]  K. Yanagihara,et al.  Lipopolysaccharide Induces Mucus Cell Metaplasia in Mouse Lung. , 2001, American journal of respiratory cell and molecular biology.